BridgeMD
New treatment option for Aphasia
Official title Neural Bases of Vocal Sensorimotor Impairment in Aphasia
ClinicalTrials.gov ID: NCT04742894
What this study is testing
- What it's testing
- Aphasia is the most common type of post-stroke communication disorder characterized by deficits in speech comprehension, production and control. While recovery can be promoted with speech therapy, improvement remains modest and typically requires a large number of sessions contributing to rising health care costs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 75. Healthy volunteers may be eligible.
You may be able to join if
- A total of 50 individuals with aphasia due to chronic left hemisphere stroke (\> 6 months post-stroke) and 50 age- and gender-matched healthy control...
You likely can't join if
- people with moderate to severe hearing, memory, and/or cognitive impairments will be excluded for both groups. In addition, people with history of...
The study team makes the final eligibility decision.
Where it's taking place
- Irvine, California, United States
- Columbia, South Carolina, United States
- Richardson, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Irvine, California, United States; Columbia, South Carolina, United States; Richardson, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.